Arisaph Pharmaceuticals Inc
3 clinical trials · Sponsor
◉ Watch Arisaph Pharmaceuticals Inc
| Record | Firm | Date |
|---|---|---|
| A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis (NCT02574325) | Arisaph Pharmaceuticals Inc | 2015-10-01 |
| Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia (NCT02532218) | Arisaph Pharmaceuticals Inc | 2015-08-01 |
| Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia (NCT02250105) | Arisaph Pharmaceuticals Inc | 2014-09-01 |
Track Arisaph Pharmaceuticals Inc automatically
Every clearance here is in the API, with alerts when new ones post.